These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11140434)

  • 21. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
    Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
    Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of the dose of fluticasone propionate inhaled by infants after bronchiolitis: Effect on urinary cortisol excretion.
    Wong J; Davies T; O'Callaghan C
    J Allergy Clin Immunol; 2002 Nov; 110(5):721-7. PubMed ID: 12417880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of intravenous fluticasone propionate in healthy subjects.
    Mackie AE; Ventresca GP; Fuller RW; Bye A
    Br J Clin Pharmacol; 1996 Jun; 41(6):539-42. PubMed ID: 8799519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity.
    Lawrence M; Wolfe J; Webb DR; Chervinsky P; Kellerman D; Schaumberg JP; Shah T
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):744-51. PubMed ID: 9309988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
    Kim KT; Milgrom H; Yoon YK; Levy AL; Matz P; Welch MJ; Cahn A; Collins DA; Kathman S; Mehta R; Su SF; Kunka RL
    J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Derom E; Van Schoor J; Verhaeghe W; Vincken W; Pauwels R
    Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.
    Wilson AM; McFarlane LC; Lipworth BJ
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1274-7. PubMed ID: 9351634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
    Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays.
    Daley-Yates PT; Kunka RL; Yin Y; Andrews SM; Callejas S; Ng C
    Eur J Clin Pharmacol; 2004 Jun; 60(4):265-8. PubMed ID: 15114430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate.
    Dempsey OJ; Coutie WJ; Wilson AM; Williams P; Lipworth BJ
    Thorax; 1999 Jul; 54(7):614-7. PubMed ID: 10377207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
    Sheth KK; Cook CK; Philpot EE; Prillaman BA; Witham LA; Faris MA; Klein KC; Rickard KA
    Allergy Asthma Proc; 2004; 25(2):115-20. PubMed ID: 15176496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
    LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.
    Fardon TC; Lee DK; Haggart K; McFarlane LC; Lipworth BJ
    Am J Respir Crit Care Med; 2004 Nov; 170(9):960-6. PubMed ID: 15184207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
    Nielsen LP; Dahl R
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The human pharmacology of fluticasone propionate.
    Harding SM
    Respir Med; 1990 Nov; 84 Suppl A():25-9. PubMed ID: 2287792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
    Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R
    Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in lung bioavailability between different propellants for fluticasone propionate.
    Wilson AM; Sims EJ; Orr LC; Lipworth BJ
    Lancet; 1999 Oct; 354(9187):1357-8. PubMed ID: 10533870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
    O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.